Schedule 13D ownership disclosure

aTYR PHARMA INC

Security class unavailable · CUSIP: 002120103

Event date: 2018-05-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,694,528
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-030722
Form type
SC 13D/A
Filer
Sofinnova Venture Partners IX, L.P.
CIK
CIK 1612133
Filed
May 24, 2018
Reporting period
May 15, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub